Luminex Corp. Launches Its First Pharmacogenomics Test for Personalized Medicine
Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
pharmacogenomics
Bringing a Personal Touch to Treatment Decisions
Having a detailed overview of the patient’s life and health could aid in determining the mechanisms that caused a disease to develop.